Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS)

NCT00120653 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Myelodysplastic Syndromes

Interventions

DRUG: Metoclopramide

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)